Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy

NCT03948477 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Oncology
Breast Cancer
Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Pantoprazole 40mg
DRUG: Placebo

Sponsor

University of Auckland, New Zealand